RSS feed

Publications by Thomas G. von Lueder

47 publications found

Original articles

Fyksen TS, Vanberg P, Gjesdal K, von Lueder TG, Bjørnerheim R, Steine K, Atar D, Halvorsen S (2022)
Cardiovascular phenotype of long-term anabolic-androgenic steroid abusers compared with strength-trained athletes
Scand J Med Sci Sports, 32 (8), 1170-1181
DOI 10.1111/sms.14172, PubMed 35460300

Kasiakogias A, Rosei EA, Camafort M, Ehret G, Faconti L, Ferreira JP, Brguljan J, Januszewicz A, Kahan T, Manolis A, Tsioufis K, Weber T, von Lueder TG, Smiseth OA, Wachtell K, Kjeldsen SE, Zannad F, Mancia G, Kreutz R (2021)
Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension
J Hypertens, 39 (8), 1522-1545
DOI 10.1097/HJH.0000000000002910, PubMed 34102660

Voll M, Øystese KA, Høiskar E, Johansen O, Nyvold C, Norheim I, von Lueder TG, Andersen GØ (2021)
Case report: a patient with thyroid storm, refractory cardiogenic shock, and cardiac arrest treated with Lugol's iodine solution and veno-arterial extra corporal membrane oxygenation support
Eur Heart J Case Rep, 5 (2), ytab017
DOI 10.1093/ehjcr/ytab017, PubMed 33569532

Iversen PO, von Lueder TG, Kardel KR, Lien K (2020)
Cardiac Dimensions and Function Are Not Altered among Females with the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Healthcare (Basel), 8 (4)
DOI 10.3390/healthcare8040406, PubMed 33081294

Kotecha D, Gill SK, Flather MD, Holmes J, Packer M, Rosano G, Böhm M, McMurray JJV, Wikstrand J, Anker SD, van Veldhuisen DJ, Manzano L, von Lueder TG, Rigby AS, Andersson B, Kjekshus J, Wedel H, Ruschitzka F, Cleland JGF, Damman K, Redon J, Coats AJS, Beta-Blockers in Heart Failure Collaborative Group (2019)
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure
J Am Coll Cardiol, 74 (23), 2893-2904
DOI 10.1016/j.jacc.2019.09.059, PubMed 31806133

Hall TS, von Lueder TG, Zannad F, Rossignol P, Duarte K, Chouihed T, Solomon SD, Dickstein K, Atar D, Agewall S, Girerd N, High-Risk Myocardial Infarction Database Initiative investigators (2019)
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction
Am Heart J, 215, 83-90
DOI 10.1016/j.ahj.2019.06.004, PubMed 31291604

von Lueder TG, Atar D, Agewall S, Jensen JK, Hopper I, Kotecha D, Mentz RJ, Kim MH, Serebruany VL (2019)
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System
Am J Ther, 26 (6), e671-e678
DOI 10.1097/MJT.0000000000000883, PubMed 31145139

Kompa AR, Lu J, Weller TJ, Kelly DJ, Krum H, von Lueder TG, Wang BH (2018)
Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction
Int J Cardiol, 258, 192-198
DOI 10.1016/j.ijcard.2018.01.077, PubMed 29544929

Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS, Manzano L, McMurray JJV, Ruschitzka F, van Veldhuisen DJ, von Lueder TG, Böhm M, Andersson B, Kjekshus J, Packer M, Rigby AS, Rosano G, Wedel H, Hjalmarson Å, Wikstrand J, Kotecha D, Beta-blockers in Heart Failure Collaborative Group (2018)
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
Eur Heart J, 39 (1), 26-35
DOI 10.1093/eurheartj/ehx564, PubMed 29040525

Agewall S, Tjessem LH, Rossignol P, Zannad F, Atar D, Lamiral Z, Machu JL, Dickstein K, Kjekshus J, von Lueder TG, Girerd N, High Risk Myocardial Infarction Database Initiative investigators (2017)
Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative
Int J Cardiol, 249, 274-281
DOI 10.1016/j.ijcard.2017.09.182, PubMed 28964557

Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, Packer M, Coats AJS, Manzano L, Böhm M, van Veldhuisen DJ, Andersson B, Wedel H, von Lueder TG, Rigby AS, Hjalmarson Å, Kjekshus J, Cleland JGF, Beta-Blockers in Heart Failure Collaborative Group (2017)
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure
J Am Coll Cardiol, 69 (24), 2885-2896
DOI 10.1016/j.jacc.2017.04.001, PubMed 28467883

von Lueder TG, Hodt A, Gjerdalen GF, Steine K (2017)
Left ventricular biomechanics in professional football players
Scand J Med Sci Sports, 28 (1), 187-195
DOI 10.1111/sms.12893, PubMed 28378431

von Lueder TG, Kotecha D, Atar D, Hopper I (2017)
Neurohormonal Blockade in Heart Failure
Card Fail Rev, 3 (1), 19-24
DOI 10.15420/cfr.2016:22:2, PubMed 28785471

Kotecha D, Manzano L, Krum H, Rosano G, Holmes J, Altman DG, Collins PD, Packer M, Wikstrand J, Coats AJ, Cleland JG, Kirchhof P, von Lueder TG, Rigby AS, Andersson B, Lip GY, van Veldhuisen DJ, Shibata MC, Wedel H, Böhm M, Flather MD, Beta-Blockers in Heart Failure Collaborative Group (2016)
Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
BMJ, 353, i1855
DOI 10.1136/bmj.i1855, PubMed 27098105

von Lueder TG, Girerd N, Atar D, Agewall S, Lamiral Z, Kanbay M, Pitt B, Dickstein K, Zannad F, Rossignol P, High-Risk Myocardial Infarction Database Initiative Investigators (2015)
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative
Eur J Heart Fail, 17 (11), 1144-51
DOI 10.1002/ejhf.419, PubMed 26424212

von Lueder TG, Wang BH, Kompa AR, Huang L, Webb R, Jordaan P, Atar D, Krum H (2014)
Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy
Circ Heart Fail, 8 (1), 71-8
DOI 10.1161/CIRCHEARTFAILURE.114.001785, PubMed 25362207

Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG, Lip GY, Coats AJ, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD, Beta-Blockers in Heart Failure Collaborative Group (2014)
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis
Lancet, 384 (9961), 2235-43
DOI 10.1016/S0140-6736(14)61373-8, PubMed 25193873

von Lueder TG, Atar D (2014)
Comorbidities and polypharmacy
Heart Fail Clin, 10 (2), 367-72
DOI 10.1016/j.hfc.2013.12.001, PubMed 24656112

von Lueder TG, Sangaralingham SJ, Wang BH, Kompa AR, Atar D, Burnett JC, Krum H (2013)
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure
Circ Heart Fail, 6 (3), 594-605
DOI 10.1161/CIRCHEARTFAILURE.112.000289, PubMed 23694773

Gravning J, Ahmed MS, von Lueder TG, Edvardsen T, Attramadal H (2013)
CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload
Int J Cardiol, 168 (3), 2049-56
DOI 10.1016/j.ijcard.2013.01.165, PubMed 23452880

von Lueder TG, Gravning J, How OJ, Vinge LE, Ahmed MS, Krobert KA, Levy FO, Larsen TS, Smiseth OA, Aasum E, Attramadal H (2012)
Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload
Am J Physiol Heart Circ Physiol, 303 (1), H66-74
DOI 10.1152/ajpheart.00724.2011, PubMed 22542621

Von Lueder TG, Melsom MN, Atar D, Agewall S (2011)
Amyotrophic lateral sclerosis (ALS), a novel rare cause of elevated plasma troponin T levels
Clin Lab, 57 (7-8), 615-8
PubMed 21888026

Ahmed MS, Gravning J, Martinov VN, von Lueder TG, Edvardsen T, Czibik G, Moe IT, Vinge LE, Øie E, Valen G, Attramadal H (2010)
Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, 300 (4), H1291-302
DOI 10.1152/ajpheart.00604.2010, PubMed 21186275

Iversen PO, Andersson KB, Finsen AV, Sjaastad I, von Lueder TG, Sejersted OM, Attramadal H, Christensen G (2009)
Separate mechanisms cause anemia in ischemic vs. nonischemic murine heart failure
Am J Physiol Regul Integr Comp Physiol, 298 (3), R808-14
DOI 10.1152/ajpregu.00250.2009, PubMed 20032264

Vinge LE, von Lueder TG, Aasum E, Qvigstad E, Gravning JA, How OJ, Edvardsen T, Bjørnerheim R, Ahmed MS, Mikkelsen BW, Oie E, Attramadal T, Skomedal T, Smiseth OA, Koch WJ, Larsen TS, Attramadal H (2007)
Cardiac-restricted expression of the carboxyl-terminal fragment of GRK3 Uncovers Distinct Functions of GRK3 in regulation of cardiac contractility and growth: GRK3 controls cardiac alpha1-adrenergic receptor responsiveness
J Biol Chem, 283 (16), 10601-10
DOI 10.1074/jbc.M708912200, PubMed 18165681

Ahmed MS, Øie E, Vinge LE, von Lueder TG, Attramadal T, Attramadal H (2006)
Induction of pulmonary connective tissue growth factor in heart failure is associated with pulmonary parenchymal and vascular remodeling
Cardiovasc Res, 74 (2), 323-33
DOI 10.1016/j.cardiores.2006.12.010, PubMed 17254558

Ahmed MS, von Lueder TG, Øie E, Kjekshus H, Attramadal H (2005)
Induction of myocardial connective tissue growth factor in pacing-induced heart failure in pigs
Acta Physiol Scand, 184 (1), 27-36
DOI 10.1111/j.1365-201X.2005.01416.x, PubMed 15847641

von Lueder TG, Kjekshus H, Edvardsen T, ØIe E, Urheim S, Vinge LE, Ahmed MS, Smiseth OA, Attramadal H (2004)
Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1
Cardiovasc Res, 63 (1), 41-50
DOI 10.1016/j.cardiores.2004.03.016, PubMed 15194460

Review articles

Kjeldsen SE, von Lueder TG, Smiseth OA, Wachtell K, Mistry N, Westheim AS, Hopper I, Julius S, Pitt B, Reid CM, Devereux RB, Zannad F (2019)
Medical Therapies for Heart Failure With Preserved Ejection Fraction
Hypertension, 75 (1), 23-32
DOI 10.1161/HYPERTENSIONAHA.119.14057, PubMed 31786973

Chin KL, Ofori-Asenso R, Hopper I, von Lueder TG, Reid CM, Zoungas S, Wang BH, Liew D (2019)
Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies
Cardiovasc Res, 115 (2), 266-276
DOI 10.1093/cvr/cvy295, PubMed 30475996

Hall TS, von Lueder TG, Zannad F, Rossignol P, Duarte K, Chouihed T, Dickstein K, Atar D, Agewall S, Girerd N, High-Risk Myocardial Infarction Database Initiative investigators (2018)
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction
Int J Cardiol, 272, 260-266
DOI 10.1016/j.ijcard.2018.07.137, PubMed 30144995

Hopper I, Kotecha D, Chin KL, Mentz RJ, von Lueder TG (2016)
Comorbidities in Heart Failure: Are There Gender Differences?
Curr Heart Fail Rep, 13 (1), 1-12
DOI 10.1007/s11897-016-0280-1, PubMed 26829930

von Lueder TG, Krum H (2015)
New medical therapies for heart failure
Nat Rev Cardiol, 12 (12), 730-40
DOI 10.1038/nrcardio.2015.137, PubMed 26416006

Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CS, Cowie MR, Kjeldsen K, Jankowska EA, Atar D, Butler J, Fiuzat M, Zannad F, Pitt B, O'Connor CM (2014)
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction
J Am Coll Cardiol, 64 (21), 2281-93
DOI 10.1016/j.jacc.2014.08.036, PubMed 25456761

von Lueder TG, Atar D, Krum H (2014)
Current role of neprilysin inhibitors in hypertension and heart failure
Pharmacol Ther, 144 (1), 41-9
DOI 10.1016/j.pharmthera.2014.05.002, PubMed 24836726

von Lueder TG, Atar D, Krum H (2013)
Diuretic use in heart failure and outcomes
Clin Pharmacol Ther, 94 (4), 490-8
DOI 10.1038/clpt.2013.140, PubMed 23852396

von Lueder TG, Krum H (2013)
RAAS inhibitors and cardiovascular protection in large scale trials
Cardiovasc Drugs Ther, 27 (2), 171-9
DOI 10.1007/s10557-012-6424-y, PubMed 23224653

von Lueder TG, Krum H (2012)
Current modalities for invasive and non-invasive monitoring of volume status in heart failure
Heart, 98 (13), 967-73
DOI 10.1136/heartjnl-2011-301330, PubMed 22572046

Other articles

Kjeldsen SE, Atar D, von Lueder TG (2019)
Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapy
Eur Heart J Cardiovasc Pharmacother, 5 (2), 122-123
DOI 10.1093/ehjcvp/pvz005, PubMed 30698668

von Lueder TG, Agewall S (2018)
The burden of heart failure in the general population: a clearer and more concerning picture
J Thorac Dis, 10 (Suppl 17), S1934-S1937
DOI 10.21037/jtd.2018.04.153, PubMed 30023084

von Lueder TG, Hopper I, Kotecha D, Atar D (2016)
In memoriam Henry Krum, 1958-2015
Cardiology, 134 (2), 107-8
DOI 10.1159/000444294, PubMed 26950607

von Lueder TG, Girerd N (2016)
The Prognostic Role of Serum Uric Acid (SUA) in Coronary Artery Disease: PerSUAsive Data Plea for a Large Morbidity-Mortality Trial
Cardiology, 134 (3), 357-9
DOI 10.1159/000444744, PubMed 27007801

Hopper I, Skiba M, von Lueder TG, Watanabe M, Funston R, Tonkin A, Krum H (2015)
Digoxin withdrawal worsens clinical status in stable patients with heart failure receiving optimal contemporaneous therapy--a randomized controlled trial
J Card Fail, 21 (9), 779-81
DOI 10.1016/j.cardfail.2015.07.003, PubMed 26169443

Kotecha D, von Lueder TG (2015)
Qualifying the use of common cardiovascular drugs in cardiology
Circ J, 79 (3), 517-8
DOI 10.1253/circj.CJ-15-0088, PubMed 25746532

Wang BH, von Lueder TG, Kompa AR, Huang L, Webb R, Jordaan P, Atar D, Krum H (2015)
Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis
Int J Cardiol, 186, 104-5
DOI 10.1016/j.ijcard.2015.03.116, PubMed 25828104

Books

Von Lueder TG (2009)
Molecular mechanisms of myocardial hypertrophy and heart failure: experimental studies on cardiac G protein-coupled receptor signaling with emphasis on endothelin-1
In Hjerteforum, Supplement, Norsk cardiologisk selskap, Oslo, 22(2009)2b, 1 b. (flere pag.)
BIBSYS 100067271

Theses

Von Lueder TG (2009)
Molecular mechanisms of myocardial hypertrophy and heart failure: experimental studies on cardiac G protein-coupled receptor signaling with emphasis on endothelin-1
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 810, 1 b. (flere pag.)
BIBSYS 093346751, ISBN 978-82-8072-799-2